Publications by authors named "Gregory M Pinon"

Claim this Profile
S
Structural determinants of ligand binding to the mineralocorticoid receptor.
Jessica Huyet, Grégory Maurice Pinon, Michel Raymond Fay, Marie-Edith Rafestin-Oblin, Jérôme Fagart

Mol Cell Endocrinol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of spirolactone recognition by the mineralocorticoid receptor.
Jessica Huyet, Grégory M Pinon, Michel R Fay, Jérôme Fagart, Marie-Edith Rafestin-Oblin

Mol Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor.
Armelle-Natsuo Takeda, Grégory M Pinon, Marcelle Bens, Jérôme Fagart, Marie-Edith Rafestin-Oblin

Mol Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension.
Jérôme Fagart, Jessica Huyet, Grégory M Pinon, Marina Rochel, Claudine Mayer

Nat Struct Mol Biol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Met852 residue is a key organizer of the ligand-binding cavity of the human mineralocorticoid receptor.
Jérôme Fagart, Cendrine Seguin, Grégory Maurice Pinon, Marie-Edith Rafestin-Oblin

Mol Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dehydroepiandrosterone and its 7-hydroxylated metabolites do not interfere with the transactivation and cellular trafficking of the glucocorticoid receptor.
Caroline Muller, Françoise Cluzeaud, Gregory M Pinon, Marie-Edith Rafestin-Oblin, Robert Morfin

J Steroid Biochem Mol Biol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
Grégory Maurice Pinon, Jérôme Fagart, Anny Souque, Gilles Auzou, Alain Vandewalle

Mol Cell Endocrinol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis